Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma Authors retain all rights in ...
Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...
Please provide your email address to receive an email when new articles are posted on . Fixed-duration pirtobrutinib plus venetoclax with or without rituximab was well-tolerated in relapsed or ...
MANCHESTER, England — Two new randomized controlled trials (RCTs) assessing the role of rituximab in the treatment of various stages of systemic lupus erythematosus (SLE) have the green light to start ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Off-label ...
The patient was successfully treated with rituximab and intravenous immunoglobulin. Patients with flares of systemic lupus erythematosus (SLE), multiple organ involvement, and infections can pose a ...
Rituximab effectively reduced skin sclerosis and appeared to have a beneficial effect on interstitial lung disease (ILD) for patients with systemic sclerosis (SSc) in a randomized, clinical trial. At ...
Truxima is a prescription drug used to treat certain blood cancers and rheumatoid arthritis. It can cause side effects ranging from mild (such as nausea and fatigue) to serious, including kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback